UCBI Logo.png
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common and Preferred Stock
November 14, 2024 16:45 ET | United Community Banks, Inc.
GREENVILLE, S.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”, the “Company”), reported that its Board of Directors approved a quarterly cash dividend of...
UCBI Logo.png
United Community Banks, Inc. Reports Third Quarter Results
October 23, 2024 07:30 ET | United Community Banks, Inc.
GREENVILLE, S.C. , Oct. 23, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the 2024 third quarter of $47.3 million and pre-tax,...
UCBI Logo.png
United Community Banks, Inc. Announces Date for Third Quarter 2024 Earnings Release and Conference Call
September 27, 2024 15:00 ET | United Community Banks, Inc.
GREENVILLE, S.C., Sept. 27, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) announces it will release its third quarter 2024 financial results on Wednesday, October 23, 2024 before...
Picture1.png
United Community Banks, Inc. Announces Increased Quarterly Cash Dividend and Larger Share Repurchase Program on Common Stock and Declares Preferred Stock Dividend
August 15, 2024 16:30 ET | United Community Banks, Inc.
GREENVILLE, S.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”, the “Company”), reported that its Board of Directors approved a 4% quarterly cash dividend...
Conflicting Views Be
Conflicting Views Between Epileptologists and General Neurologists Hinder Adoption of New Refractory Epilepsy Treatments
July 08, 2024 11:36 ET | Spherix Global Insights
EXTON, PA, July 08, 2024 (GLOBE NEWSWIRE) -- Chronic epilepsy is often well managed by neurologists, but a sizable proportion of adults with epilepsy continue to experience seizures at varying...
Picture1.png
United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference Call
June 28, 2024 16:30 ET | United Community Banks, Inc.
GREENVILLE, S.C., June 28, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NASDAQ: UCBI) announces it will release its second quarter 2024 financial results on Wednesday, July 24, 2024 before...
US Neurologists Repo
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson’s Disease Treatments
May 09, 2024 09:31 ET | Spherix Global Insights
Exton, Pennsylvania, May 09, 2024 (GLOBE NEWSWIRE) -- Even as the incidence of Parkinson’s disease (PD) continues to increase with 90,000 new diagnoses each year1 in the US, the treatment landscape...
Picture1.png
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
February 16, 2024 16:15 ET | United Community Banks, Inc.
GREENVILLE, S.C., Feb. 16, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NASDAQ: UCBI) (“United”), reported that its Board of Directors approved a quarterly cash dividend of $429.6875 per...
Picture1.png
United Community Banks, Inc. Reports Fourth Quarter Results
January 24, 2024 07:30 ET | United Community Banks, Inc.
GREENVILLE, S.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NASDAQ: UCBI) (“United”) today announced net income for the fourth quarter of $14.1 million and pre-tax,...
Changes Afoot for th
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
January 22, 2024 10:47 ET | Spherix Global Insights
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld their...